Impressive Vertex hepatitis C drug data unveiled
November 1, 2008 - A closely watched hepatitis C treatment being developed by Vertex Pharmaceuticals Inc showed an impressive ability to knock out the virus in patients who failed other treatments and those not previously treated for the serious liver disease, data from mid-stage studies show.
U.S. hepatitis A vaccine rates vary widely
January 25, 2012 — NEW YORK (Reuters Health) - Although about 85 percent of kids in two U.S. states have had a complete set of hepatitis A vaccines, overall just three in 10 have had both shots, according to a new survey from the Centers for Disease Control and Prevention (CDC).
Most toddler vaccines not linked to blood disease
January 10, 2012 — NEW YORK (Reuters Health) - Although the MMR vaccine has been linked to a heightened risk of a rare blood disorder, other childhood vaccines do not appear to be, researchers reported Monday.
New DNA reader to bring genetics to clinics
January 10, 2012 — NEW YORK (Reuters) - A new DNA reader could bring genetics to medical clinics.
Select news items provided by Reuters Health